Retinal complications during interferon therapy for chronic hepatitis C

American Journal of Gastroenterology

Volumn 91, Issue 2, 1996, Pages 309-313

  Kawano, Tetsu ^b   Shigehira, Masafumi ^b   Uto, Hirofumi ^b   Nakama, Tetsufumi ^b   Kato, Junya ^b   Hayashi, Katsuhiro ^b   Maruyama, Toshihiro ^b   Kuribayashi, Tadanobu ^b   Chuman, Tomomi ^b   Futami, Toshiko ^b   Tsubouchi, Hirohito ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; DEPRESSION; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HEPATITIS C; HUMAN; HYPERTHYROIDISM; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETINA DISEASE; THROMBOCYTOPENIA;

ADULT; AGED; CHOLESTEROL, LDL; CHRONIC DISEASE; DIABETES COMPLICATIONS; FEMALE; FUNDUS OCULI; HEPATITIS C; HUMANS; HYPERTENSION; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON-ALPHA; INTERFERONS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; RETINA; RETINAL DISEASES; RETINAL HEMORRHAGE; TIME FACTORS;

EID: 0030064354     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Picciotto A, Varagona G, Cianciosi P, et al. Thyroid function and interferon treatment in chronic hepatitis C. Gut 1993;34:574.
2. Horning SJ, Merigan TC, Krown SE, et al. Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial. Cancer 1985;56:1305-10.
3. Renault PF, Hoofnagle JH, Park Y, et al. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987;147:1577-80.
4. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350-6.
5. Ikebe T, Nakatsuka K, Goto M, et al. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn 1990; 41:2291-6.
6. Seki K, Itou Y, Nishi Y, et al. Interferon therapy for type C chronic active hepatitis and retinal hemorrhage. Acta Hepatol Jpn 1993;34: 385-91.
7. International group. Acute and chronic hepatitis revisited. Lancet 1977;II:914-9.
8. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989;107:244-9.
9. Newell FW. The retina. In: Ophthalmology. Principles and concepts, 7th ed. St. Louis: Mosby Year Book, 1992:284-317.
10. Myron Y, Ben SF. Ocular Pathology: A text and atlas, 3rd ed. Philadelphia: Lippincott, 1989.
11. Richard AS, Forbes N, Darryl P, et al. Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration. Clin Pharmacol Ther 1985;37:85-8.
12. Dollery CT. The retinal circulation in hypertension and diabetes. Sci Basis Med Annu Rev 1969;44-59.
13. Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 1989;38:641-7.
14. Pober JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol 1998;133:426-33.
15. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-73.